METASTATIC BLADDER CARCINOMA
Clinical trials for METASTATIC BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat bladder cancers: drug targets genetic weakness
Disease control TerminatedThis study tests a drug called olaparib in people with advanced bladder or related cancers that have certain DNA repair problems. The drug works by blocking a protein that helps cancer cells fix themselves, which may stop tumor growth. About 60 adults with these specific gene cha…
Matched conditions: METASTATIC BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
New combo aims to tame Immunotherapy's side effects in advanced cancers
Disease control OngoingThis study tests whether adding tocilizumab to standard immunotherapy (ipilimumab and nivolumab) can reduce severe side effects in people with advanced melanoma, lung cancer, or bladder cancer. About 35 participants will receive the combination to see if it is safer and still eff…
Matched conditions: METASTATIC BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:57 UTC